Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Investment in Stream TV

18 Sep 2017 07:00

RNS Number : 9352Q
Primorus Investments PLC
18 September 2017
 

Primorus Investments plc

("Primorus" or the "Company")

Investment in Stream TV

Primorus Investments plc (AIM: PRIM, NEX: PRIM) pleased to announce a US$200,000 equity investment in Stream TV Networks, Inc. ("Stream TV") on a fully-diluted valuation of US$336m.

 

Stream TV is a Philadelphia-based new media company created to serve a consumer market seeking enhanced entertainment and communications experiences through devices with unlimited accessibility and superior quality. Through its wholly-owned research subsidiary, SeeCubic B.V., Stream TV has developed breakthrough glasses-free 3D display technology launched under the trade name Ultra-DT. Stream TV is on the cusp of commercially launching, via licence, a range of TV, tablet and smartphone glasses-less 3D screens in 2018. Further licenced products will follow including laptops, PCs, gaming, medical, and automotive. Stream TV intends to IPO on NASDAQ in 2018.

Stream TV currently has small revenues from licenced sales of its screens for digital signage. It made an operating loss of US$18.9m and a net loss of US$42.6m in the year ended 31 December 2016, partly due to US$12.25m of R&D costs.

Following the investment in Stream TV noted above, the Company will have available cash resources of approximately £350,000.

Alastair Clayton, Executive Director commented:

 

"Primorus is very excited to be able to participate in what we believe will be the next generation of visual screens. We have been tracking the company for several years and believe the next 12 months will be transformational for the business as years of R&D convert into commercial products. In a world where 3D TVs with glasses have failed to gain momentum and where tablet and smartphone manufacturers need to demonstrate a strong differentiation for their next generation of models, Ultra-D is extremely well-positioned to be the technology that drives the replacement cycle."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:

Primorus Investments plc:

+44 (0) 20 7440 0640

Alastair Clayton

 

 

 

Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

 

James Caithie / Sandy Jamieson

 

 

 

Broker:

+44 (0) 20 3137 1902

Optiva Securities Limited

 

Christian Dennis / Jeremy King

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFMFLIFWSELU
Date   Source Headline
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement
20th Sep 20247:00 amRNSFurther Investment in Fresho Pty Ltd
5th Sep 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.